Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Inhibitor SourceBook™ Second Edition
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Index<br />
NF-kB Activation <strong>Inhibitor</strong> II, JSH-23 ......................... 56<br />
NGIC-I ......................................................................................39<br />
Niflumic Acid ...................................................................87, 97<br />
L-NIL, Dihydrochloride .......................................................<br />
NIPP- , His•Tag ® , Bovine Thymus,<br />
Recombinant, E. coli .......................................................60<br />
Nitric Oxide Assay Kit, Colorimetric .............................. 2<br />
Nitric Oxide Assay Kit, Fluorometric .............................. 2<br />
Nitric Oxide Synthase Assay Kit ...................................... 2<br />
Nitric Oxide Synthase Assay Kit, Colorimetric ............ 2<br />
Nitric Oxide Synthase, Inducible, <strong>Inhibitor</strong> Set .......... 2<br />
p-Nitroblue Tetrazolium Chloride...................................<br />
7-Nitroindazole ...................................................................<br />
7-Nitroindazole, 3-Bromo-, Sodium Salt .....................<br />
7-Nitroindazole, Sodium Salt ..........................................<br />
N G -Nitro-L-arginine ...........................................................<br />
N G -Nitro-L-arginine Methyl Ester, Hydrochloride .....<br />
5-Nitro-2-(3-phenylpropyl-amino)benzoic Acid .........87<br />
NLVS ....................................................................................... 37<br />
nNOS <strong>Inhibitor</strong> I...................................................................<br />
NOS <strong>Inhibitor</strong> Set ................................................................ 2<br />
Novobiocin, Sodium Salt .....................................................72<br />
NP-LLL-VS ............................................................................ 37<br />
NPPB ..................................................................................23, 26<br />
NS-398 .....................................................................................87<br />
NS 2028 ................................................................................ 06<br />
N-SMase <strong>Inhibitor</strong>, GW4869 .............................................93<br />
NU 025 ....................................................................................79<br />
O<br />
ODQ ........................................................................................ 06<br />
Okadaic Acid, Ammonium Salt ..........................................60<br />
Okadaic Acid, Potassium Salt ............................................6<br />
Okadaic Acid, Prorocentrum concavum ..........................60<br />
InSolution Okadaic Acid,<br />
Prorocentrum concavum ...............................................60<br />
Okadaic Acid, Sodium Salt .................................................6<br />
Oligomycin .................................................................. 43, 5<br />
Olomoucine ............................................................................. 7<br />
InSolution Olomoucine ..................................................... 7<br />
Olomoucine II ......................................................................... 7<br />
Olomoucine, Iso- ................................................................... 7<br />
Olomoucine, N 9 -Isopropyl- ................................................. 7<br />
InSolution OM99-2 ......................................................... 0<br />
Omeprazole .......................................................................... 43<br />
Omi/HtrA2 Protease <strong>Inhibitor</strong>, Ucf- 0 ..........................67<br />
Oridonin, R. rubescens ...................................................... 56<br />
Ouabain, Octahydrate ....................................................... 43<br />
Oxamflatin ..............................................................................74<br />
Oxindole I ................................................................................5<br />
P<br />
p38 MAP Kinase <strong>Inhibitor</strong> ...................................................26<br />
p38 MAP Kinase <strong>Inhibitor</strong> III ..............................................26<br />
InSolution p38 MAP Kinase <strong>Inhibitor</strong> III ...............26, 84<br />
p-APMSF, Hydrochloride .................................................. 26<br />
PACOCF 3 ...................................................................................94<br />
PARP Cleavage Detection Kit .............................................79<br />
PARP <strong>Inhibitor</strong> Set ................................................................79<br />
Parthenolide, Tanacetum parthenium .......................... 56<br />
,3-PBITU, Dihydrobromide ..............................................<br />
PD 98059 .................................................................................26<br />
PD 45305 ............................................................................ 6<br />
PD 50606 ............................................................................ 6<br />
PD 5 746 ............................................................................. 6<br />
PD 53035 ..............................................................................5<br />
InSolution PD 53035 ......................................................5<br />
PD 56273 ..............................................................................5<br />
PD 58780 ..............................................................................5<br />
InSolution PD 58780 ......................................................84<br />
PD 68393 ..............................................................................5<br />
PD 693 6 ...............................................................................26<br />
PD 74265 ..............................................................................5<br />
PDGF Receptor Tyrosine Kinase <strong>Inhibitor</strong> I ....................5<br />
PDGF Receptor Tyrosine Kinase <strong>Inhibitor</strong> II ...................5<br />
PDGF Receptor Tyrosine Kinase <strong>Inhibitor</strong> III ..................5<br />
DL-threo-PDMP, Hydrochloride...................................... 48<br />
a -PDX, Human, Recombinant, E. coli ......................... 30<br />
Pentoxifylline ..........................................................................70<br />
Pepstatin A Methyl Ester .................................................. 0<br />
Pepstatin A, Synthetic....................................................... 30<br />
Pfmrk <strong>Inhibitor</strong>, WR 2 6 74 .............................................. 7<br />
Phenylarsine Oxide ...............................................................6<br />
Phenylmethylsulfonyl Fluoride ...................................... 30<br />
Phloretin ..................................................................................39<br />
PHM-L LIPOSORB Absorbent ..........................................90<br />
Phorbol- 2, 3-dibutyrate ............................................... 43<br />
Phosphatase <strong>Inhibitor</strong> Cocktail Set I ...............................62<br />
Phosphatase <strong>Inhibitor</strong> Cocktail Set II ..............................62<br />
Phosphatase <strong>Inhibitor</strong> Cocktail Set III .............................62<br />
Phosphatase <strong>Inhibitor</strong> Cocktail Set IV .............................62<br />
5-Phosphatase <strong>Inhibitor</strong> .....................................................6<br />
Phosphodiesterase 4 <strong>Inhibitor</strong> ........................................ 58<br />
Phosphodiesterase <strong>Inhibitor</strong> Set I .................................. 58<br />
Phosphodiesterase V <strong>Inhibitor</strong> II .................................... 58<br />
Phosphoramidon, Disodium Salt .................................... 30<br />
Phosphotyrosine Phosphatase <strong>Inhibitor</strong> Set<br />
(Vanadium) .......................................................................62<br />
PI 3-Kg <strong>Inhibitor</strong> ....................................................................3<br />
PI 3-Kg <strong>Inhibitor</strong> II ................................................................32<br />
Piceatannol ....................................................... 29, 34, 39, 5<br />
Pifithrin-a ...............................................................................67<br />
Pifithrin-a, Cyclic-................................................................67<br />
PIPER .........................................................................................80<br />
PJ34 ...........................................................................................79<br />
PKC b <strong>Inhibitor</strong> .........................................................................39<br />
PKC bII /EGFR <strong>Inhibitor</strong> ............................................................39<br />
PKC i , GST-Fusion Protein, Active, Human,<br />
Recombinant, S. frugiperda..........................................42<br />
PKC m , GST-Fusion Protein, Active, Human,<br />
Recombinant, S. frugiperda..........................................42<br />
PKC n , GST-Fusion Protein, Active, Human,<br />
Recombinant, S. frugiperda..........................................42<br />
Plasminogen Activator <strong>Inhibitor</strong>- , Human,<br />
Recombinant ................................................................. 59<br />
Plasminogen Activator <strong>Inhibitor</strong>- , Mutant,<br />
Human, Recombinant ................................................. 59<br />
Plasminogen Activator <strong>Inhibitor</strong>- , Mutant,<br />
Mouse, Recombinant .................................................. 59<br />
Plasminogen Activator <strong>Inhibitor</strong>- , Rat,<br />
Recombinant ................................................................. 59<br />
Polymyxin B Sulfate .............................................................39<br />
PP Analog ..............................................................................5<br />
PP Analog II, NM-PP ................................................8, 5<br />
PP2 ............................................................................................5<br />
InSolution PP2 ....................................................................5<br />
PP3 ............................................................................................5<br />
PPACK II, Trifluoroacetate Salt ....................................... 30<br />
PPACK, Dihydrochloride .................................................... 30<br />
PPACK Dihydrochloride, Biotinylated ........................... 30<br />
PPM- 8 ......................................................................... , 56<br />
Pravastatin, Sodium Salt .....................................................89<br />
Prolyl Endopeptidase <strong>Inhibitor</strong> II ................................... 3<br />
N G -Propyl-L-arginine .........................................................<br />
Protease Arrest Reagent ................................................ 34<br />
Protease <strong>Inhibitor</strong> Cocktail Set I .................................... 32<br />
Protease <strong>Inhibitor</strong> Cocktail Set I, Animal-Free .......... 35<br />
Protease <strong>Inhibitor</strong> Cocktail Set II ................................... 32<br />
Protease <strong>Inhibitor</strong> Cocktail Set III ................................. 32<br />
Protease <strong>Inhibitor</strong> Cocktail Set III, Animal-Free ........ 35<br />
Protease <strong>Inhibitor</strong> Cocktail Set IV ................................. 33<br />
Protease <strong>Inhibitor</strong> Cocktail Set V, Animal-Free ......... 35<br />
Protease <strong>Inhibitor</strong> Cocktail Set V, EDTA-Free ............. 33<br />
Protease <strong>Inhibitor</strong> Cocktail Set VI ................................. 33<br />
Protease <strong>Inhibitor</strong> Cocktail Set VII ................................ 34<br />
Protease <strong>Inhibitor</strong> Cocktail Set VIII ............................... 34<br />
Protease <strong>Inhibitor</strong> III, Anthrax Lethal Factor<br />
(Anthrax Lethal Factor Protease <strong>Inhibitor</strong> III) ....... 3<br />
Protease <strong>Inhibitor</strong> Set ....................................................... 34<br />
Proteasome <strong>Inhibitor</strong> I ..................................................... 37<br />
InSolution Proteasome <strong>Inhibitor</strong> I .............................. 38<br />
Proteasome <strong>Inhibitor</strong> II ..................................................... 38<br />
Proteasome <strong>Inhibitor</strong> III ................................................... 38<br />
Proteasome <strong>Inhibitor</strong> IV ................................................... 38<br />
Proteasome <strong>Inhibitor</strong> VII, Antiprotealide ..................... 38<br />
Proteasome <strong>Inhibitor</strong> Set I ............................................... 38<br />
Proteasome <strong>Inhibitor</strong> Set II ............................................. 38<br />
Protein Arginine N-Methyltransferase<br />
<strong>Inhibitor</strong>, AMI- ................................................... 46, 60<br />
Protein Kinase A <strong>Inhibitor</strong> 5-24 ........................................35<br />
Protein Kinase A <strong>Inhibitor</strong> 6-22 Amide...........................35<br />
Protein Kinase A <strong>Inhibitor</strong> 4-22 Amide,<br />
Cell-Permeable, Myristoylated ....................................35<br />
Protein Kinase C <strong>Inhibitor</strong> 20-28,<br />
Cell-Permeable, Myristoylated ....................................39<br />
Protein Kinase C <strong>Inhibitor</strong> Peptide 9-3 ......................39<br />
Protein Kinase C <strong>Inhibitor</strong> Peptide 9-36 ......................39<br />
Protein Kinase C <strong>Inhibitor</strong> Set ...........................................42<br />
Protein Kinase C <strong>Inhibitor</strong>, EGF-R Fragment<br />
65 -658, Myristoylated ................................................39<br />
Protein Kinase C , His•Tag®, Human,<br />
a<br />
Recombinant, S. frugiperda..........................................42<br />
Protein Kinase C , His•Tag®, Human,<br />
bII<br />
Recombinant ....................................................................42<br />
Protein Kinase C , His•Tag®, Human,<br />
d<br />
Recombinant, S. frugiperda..........................................42<br />
Protein Kinase C Translocation <strong>Inhibitor</strong> Peptide .......40<br />
e<br />
Protein Kinase C Translocation <strong>Inhibitor</strong> Peptide,<br />
e<br />
Negative Control .............................................................40<br />
Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong> .................39<br />
z<br />
Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong>,<br />
z<br />
Myristoylated ...................................................................39<br />
Protein Kinase C , His•Tag®, Human,<br />
x<br />
Recombinant, S. frugiperda..........................................42<br />
Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong>,<br />
h<br />
Myristoylated ...................................................................39<br />
Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong> .................39<br />
θ<br />
Protein Kinase C Pseudosubstrate <strong>Inhibitor</strong>,<br />
θ<br />
Myristoylated ...................................................................39<br />
Protein Kinase C , His•Tag®,<br />
θ<br />
Human, Recombinant, S. frugiperda .........................42<br />
Protein Kinase G Ia <strong>Inhibitor</strong>, Cell-Permeable ..............44<br />
Protein Kinase G <strong>Inhibitor</strong> ..................................................44<br />
Protein Kinase <strong>Inhibitor</strong>, DMAP .........................................23<br />
Protein Phosphatase 2A <strong>Inhibitor</strong> I PP2A ,<br />
Human Kidney, Recombinant, E. coli .........................6<br />
Protein Phosphatase 2A <strong>Inhibitor</strong> I 2<br />
70 Orders Phone 800 854 34 7<br />
Calbiochem • <strong>Inhibitor</strong> SourceBook<br />
Fax 800 776 0999<br />
Web www.emdbiosciences.com/calbiochem<br />
PP2A ,<br />
Human, Recombinant, E. coli .......................................6<br />
Protein Phosphatase <strong>Inhibitor</strong> 2, Human,<br />
Recombinant, E. coli .......................................................6<br />
Protein Phosphatase <strong>Inhibitor</strong> 2, Rabbit Muscle,<br />
Recombinant, E. coli .......................................................6<br />
Protein Phosphatase <strong>Inhibitor</strong> Set II ................................62<br />
Protein Synthesis Initiation <strong>Inhibitor</strong>,<br />
NSC 9889 .......................................................... 60, 6<br />
Protein Tyrosine Phosphatase CD45 <strong>Inhibitor</strong>...............6<br />
Protein Tyrosine Phosphatase <strong>Inhibitor</strong> I ........................6<br />
Protein Tyrosine Phosphatase <strong>Inhibitor</strong> II ......................6<br />
Protein Tyrosine Phosphatase <strong>Inhibitor</strong> III .....................6<br />
Protein Tyrosine Phosphatase <strong>Inhibitor</strong> IV .....................6<br />
P-Selectin Antagonist ..........................................................70<br />
Pterostilbene, Pterocarpus marsupium ...........................87<br />
PTP B <strong>Inhibitor</strong> ......................................................................6<br />
Puromycin, Dihydrochloride ............................................ 6<br />
Puromycin, Dihydrochloride, Cell Culture-Tested ..... 6<br />
Purvalanol A ........................................................................... 7<br />
-Pyrrolidinecarbodithioic Acid, Ammonium Salt .....<br />
Q<br />
Quercetin, Dihydrate .....................................................32, 94<br />
Quinacrine, Dihydrochloride .......................................94, 98<br />
InSolution Q-VD-OPh, Non-O-methylated .................65<br />
R<br />
Radicicol, Diheterospora chlamydosporia ...............52, 87<br />
Raf Kinase <strong>Inhibitor</strong> I .........................................................55<br />
InSolution Raf Kinase <strong>Inhibitor</strong> I .................................55<br />
InSolution Rapamycin .......................................................84<br />
InSolution Ratjadone A, Synthetic ................................77<br />
Resveratrol .......................................................................87, 97<br />
RG- 3022 ................................................................................52<br />
Rho-Kinase <strong>Inhibitor</strong> ............................................................56<br />
InSolution Rho Kinase <strong>Inhibitor</strong> ..............................56, 84<br />
Rho-Kinase <strong>Inhibitor</strong> II ........................................................56<br />
Rho-Kinase <strong>Inhibitor</strong> III, Rockout .....................................56<br />
Rho Kinase <strong>Inhibitor</strong> IV ........................................................56<br />
Ribonuclease <strong>Inhibitor</strong>, Human,<br />
Recombinant, E. coli .......................................................77<br />
Ribonuclease <strong>Inhibitor</strong>, Human Placenta .......................77<br />
Rifampicin ...............................................................................72<br />
RK-682, Streptomyces sp. ...................................................6